- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT05591196
Récupération motrice de la main et du bras par stimulation électrique non invasive de la moelle épinière après un AVC (HARNESS)
The recovery from a stroke is often incomplete. It is the leading cause of acquired permanent disability in the adult population. Persistent functional loss of the hand and arm contributes significantly to disability. However, the current standard of care to treat hand and arm movements are inadequate. There is an urgent need for innovative and effective therapies for recovery of the upper limb after stroke.
Growing evidence shows that electrical spinal cord stimulation, combined with activity-dependent rehabilitation, enables voluntary movement of paralyzed muscles in some neurologic disorders, such as spinal cord injury. The investigators hypothesize that spinal networks that lost control after stroke can be activated by non-invasive electrical stimulation of the spinal cord to improve functional recovery.
The aims of the study are:
- to determine the improvements in hand and arm function that result from the combined application of non-invasive spinal stimulation and activity-based rehabilitation. Surface electrodes placed over the skin of the neck will be used for non-invasive electrical stimulation of the spinal cord. Functional task practice will be used for activity-dependent rehabilitation,
- to evaluate long-lasting benefits to hand and arm function that persist beyond the period of spinal stimulation.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Fatma Inanici
- Numéro de téléphone: 206-787-2692
- E-mail: finanici@uw.edu
Lieux d'étude
-
-
Washington
-
Seattle, Washington, États-Unis, 98105
- Recrutement
- University of Washington
-
Sous-enquêteur:
- Fatma Inanici, MD, PhD
-
Chercheur principal:
- Chet T Moritz, PhD
-
Contact:
- Fatma Inanici, MD, Ph.D.
- Numéro de téléphone: 2067872692
- E-mail: finanici@uw.edu
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Radiologically documented single ischemic stroke resulted in hemiplegia/hemiparesis
- At least six months post-stroke
- Upper Extremity Fugl-Meyer Assessment score "moderate" or "moderate-mild" (29-53 inclusive out of 66) at the screening visit
- Medically and neurologically stable, as determined by medical history and documented physical examination
- For women of childbearing potential, a negative over-the-counter pregnancy test at study entry and willingness to practice adequate contraception during the study
- Ability to attend sessions three times per week
- Adequate social support to participate in all intervention and baseline, follow-up assessment sessions throughout eight months.
- Ability to read, comprehend and speak English
Exclusion Criteria:
- Hemorrhagic stroke
- History of multiple strokes
- Active implanted stimulator (e.g., pacemaker, vagus nerve stimulator, cochlear implant, etc.) or baclofen pump
- Aphasia or any other deficit in communication that interferes with reasonable study participation
- Moderate to severe cognitive impairment
- Presence of neglect (inability to perceive or awareness of, or loss of attention to the weaker half of the body)
- Severe spasticity in the upper limb
- Taking baclofen more than 30 mg/day
- Change in baclofen dose within four weeks before enrollment
- Receiving benzodiazepines, dantrolene, tizanidine, anticoagulant, or antiepileptic medication
- Botulinum toxin injection to the upper limb muscles within six months before enrollment
- Severe joint contractures in the affected hand and arm
- History of spontaneous seizure that had occurred one month or longer after the stroke
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation croisée
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur actif: Activity Based Rehabilitation
Activity Based Rehabilitation is comprised of intensive, progressive, functional task practice. The protocol consists of repetitive activities of gross upper limb movement, isolated finger movements, bimanual task performance, simple and complex pinch, and grip performance. Several activities with various difficulty levels are designated for each category, and the participant will perform 1-2 activities within each category in each rehabilitation session. Rehabilitation sessions will be three times per week, 90 minutes per session for six weeks (total of 18 sessions). |
Exercise therapy targeting paralyzed hand and arm |
|
Expérimental: Non-invasive Electrical Spinal Cord Stimulation + Activity Based Rehabilitation
Non-invasive electrical spinal cord stimulation will be performed using surface electrodes placed over the skin of the neck. Biphasic rectangular pulses of 1 millisecond per phase duration will be delivered with a 10 kiloHertz overlapping frequency and between 20-120 Hertzz burst frequency. Non-invasive electrical spinal cord stimulation will be paired with Activity Based Rehabilitation sessions. Stimulation plus rehabilitation sessions will be three times per week, 90 minutes per session for six weeks (total of 18 sessions). |
Exercise therapy targeting paralyzed hand and arm Electrical stimulation of the spinal cord using surface electrodes |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change from baseline - Fugl-Meyer assessment of the upper limb
Délai: "Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
|
The clinician-administered a stroke-specific, performance-based impairment scale. It assesses movement function, sensation, joint range of motion, and pain. The score ranges from 0 to 66. Higher scores indicate better outcomes. |
"Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
|
|
Change from baseline - Pinch and grip force
Délai: "Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
|
Measurement of hand strengths using a dynamometry. |
"Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
|
|
Change from baseline - Modified Ashworth Scale
Délai: "Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
|
Clinician-administered test for resistance of a joint to passive movement. This scale grades muscle tone/spasticity. The score ranges from 0 to 4. Higher scores indicate worse outcomes. |
"Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
|
|
Change from baseline - Wolf Motor Function Test
Délai: "Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
|
Quantifies upper limb motor ability through timed and functional tasks. The score range is 0-75; higher scores denote better function. |
"Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change from baseline - Action Research Arm Test
Délai: "Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
|
Clinician-administered observational measure to assess upper extremity performance, such as coordination, dexterity, and functioning, in stroke recovery. |
"Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
|
|
Change from baseline - Box and Blocks Test
Délai: "Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
|
Participants move, one by one, the maximum number of blocks from one compartment of a box to another of equal size within 60 seconds. Measures gross manual dexterity. |
"Measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
|
|
Change from baseline - Revised Nottingham Sensory Assessment
Délai: "Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
|
A standardized scale for assessing sensory impairment in stroke patients. Tactile sensation, proprioception, stereognosis, and two-point discrimination are evaluated. |
"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
|
|
Change from baseline - Stroke Impact Scale
Délai: "Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
|
A self-report questionnaire that evaluates disability and health-related quality of life after stroke. The questionnaire consists of 8 domains: strength, memory and thinking, emotion, communication, activities of daily living, mobility, hand function, and participation/role function. The score ranges from 0 to 100. Higher scores indicate better outcomes. |
"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
|
|
Change from baseline - Short Form-36
Délai: "Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
|
A self-report health survey questionnaire. The score range from 0 to 100. The higher the score, the better the outcome. |
"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
|
|
Change from baseline - Patients Global Impression of Change
Délai: "Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
|
A self-report measure that reflects the participant's belief about the efficacy of treatment: the participant chooses the level of improvement and their functional status between much worse, worse, no change, improved and much improved, compared to the baseline. |
"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
|
|
Change from baseline - H-reflex test
Délai: "Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
|
Electrophysiologic evaluation of the reflex response triggered on the motor nerves when sensory fibers in the peripheral nerve are stimulated. |
"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
|
|
Change from baseline - Somatosensory evoked potentials test
Délai: "Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
|
Electrophysiologic evaluation of sensory pathways between the brain and the limb. |
"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
|
|
Change from baseline - Spinally evoked motor potentials test
Délai: "Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
|
Electrophysiologic evaluation of motor pathways between the central nervous system and the muscles. |
"Repeated measurements once at baseline, once at the end of each treatment arm and through study completion, an average of 8 months."
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Chet Moritz, PhD, University of Washington
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- STUDY00015990
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
produit fabriqué et exporté des États-Unis.
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .